Need a mobile version? http://multibriefs.com/briefs/ascls/121509.html

ASCLS eNewsBytes
Dec. 15, 2009
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

Scientists: Waste product may save lives
The Sydney Morning Herald    Share   Share on FacebookTwitterShare on LinkedinE-mail
article
Scientists believe the substance left over after donated blood is processed could contain a key to reducing deaths from heart attack. The vital substance is high-density lipoprotein, and CSL's Dr. Samuel Wright says the Australian biopharmaceutical company could recover "a few tonnes" of it from its processes every year. This reconstituted HDL could be injected into the blood streams of people with heart disease, where it would return to its ordinary function of sucking up trapped cholesterol and sending it off for disposal. More
Beckman Coulter


New additive aids blood platelet storage
HealthDay News via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An additive that allows for more efficient storage of blood platelets up to five days has been approved by the U.S. Food and Drug Administration. Platelets — the component that helps blood clot -- are commonly used to prevent or treat bleeding, are given to people having chemotherapy to treat cancer, and are administered to people who don't produce their own platelets, the agency said in a news release. More


Breast cancer hormonal therapy with "issues" is better at higher dose
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Clinicians using fulvestrant in breast cancer patients who have progressed to metastatic disease on other hormonal therapies might want to consider a 500 mg dose instead of the currently approved 250 mg dose. New data presented here at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS) show that the higher dose provided a statistically significantly longer time to disease progression than the 250 mg dose (6.5 vs 5.5 months; P = .006). More


Laboratory jobs open as recession eases
Minneapolis Star Tribune    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Clinical laboratory scientists help physicians pinpoint most diagnoses, but many are on the verge of retirement. Minnesota colleges and universities are offering more educational opportunities than ever before for those interested in entering this growing field. More

Equitech


Bone marrow transplant 'gets rid of' sickle cell anemia
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have for the first time performed a successful bone marrow transplant to cure sickle cell disease in adults, a feat that could expand the procedure to more of the 70,000 Americans with the disease — and possibly some other diseases as well. More


New DNA test could speed time to sepsis diagnosis
HealthDay News via U.S. News & World Report    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new DNA test for sepsis-causing bacteria provides results much sooner than the current gold-standard blood-culture method, a new study shows. Sepsis is a potentially fatal condition caused by the immune system's strong reaction to a serious infection. The sooner sepsis is diagnosed; the sooner infection-specific treatment can begin, leading to improved patient outcomes. More


CDC: 10,000 H1N1 flu deaths
WebMD via Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
H1N1 influenza killed 10,000 Americans, sent 213,000 to the hospital, and sickened 50 million — a sixth of the population — by mid-November, the U.S. Centers for Disease Control and Prevention estimates. The CDC's new estimates reflect a flood of new cases from mid-October to mid-November, as the current wave of the U.S. flu pandemic was climbing to its peak. The numbers represent the middle of a range of estimates made using statistical calculations to correct for underreporting of cases, hospitalizations, and deaths. More

StatSpin® CytoFuge 12
The NEW StatSpin® CytoFuge 12 is a compact, low cost cytocentrifuge that concentrates 12 samples from 50 µL up to 800 µL onto microscope slides for a variety of cell preparations. Inside is a removable sealed autoclavable rotor that can be loaded in a hood to eliminate exposure to biohazards. The program key pad is easy to use; up to 24 programs can be stored. The unit operates from 200-2,000 rpm. More info



Study finds possible explanation for the link between infertility and breast/ovarian cancer risks
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In a study published online in the Journal of Clinical Oncology, researchers concluded that mutations in the BRCA1 gene (gene associated with early onset breast cancer) are associated with early diminishment of egg reserve. This finding may, at least in part, explain the link between infertility and breast/ovarian cancer risks. More


Pennsylvania residents in cancer cluster tested for mutation
The Associated Press via Google News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Federal health researchers have tested nearly 2,200 people in northeastern Pennsylvania for a genetic mutation associated with a rare blood cancer. The testing found the mutation in 19 people, or 1.6 percent of those who participated in the study. Scientists don't yet know how prevalent this mutation is in the general population. More

This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!

Advertise

Ben Maitland, Director of Advertising Sales
972.402.7025

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor
469.420.2641.

Recent Issues

  • Dec. 8, 2009
  • Dec. 1, 2009
  • Nov. 24, 2009
  • Nov. 17, 2009
  • Nov. 10, 2009
  •  RSS Feed
    Most popular articles



    7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063